Zentalis Pharmaceuticals, Inc.
NASDAQZentalis Pharmaceuticals enters its May 14 earnings report with short sellers meaningfully more active than they were a month ago — and options traders signalling the opposite of fear. Short interest has climbed sharply over the past month. At 8.4% of free float, it is up nearly 39% versus 30 days ago, as measured by shares short. The daily history makes the acceleration clear…
ZNTL short interest surged 75% in one week to 7.7% of float, now at 5.6M shares as of April 28.
Snapshot as of 25 Jun 2026
Zentalis Pharmaceuticals enters its May 14 earnings report with short sellers meaningfully more active than they were a month ago — and options traders signalling the opposite of fear. Short interest has climbed…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for ZNTL — free to start on ORTEX.
Sign up for free →Open ZNTL on ORTEXPulses are triggered by ORTEX's live data feeds. The full signal history, thresholds, and alerts are on ORTEX.
Live ZNTL data →